In a new review, experts call for the removal of diphenhydramine from over-the-counter and prescription markets in the United ...

Patients with chronic spontaneous urticaria experience inadequate symptom control and significant emotional burdens despite ...

Received U.S. FDA approval for EMPAVELI® (pegcetacoplan) for treatment of patients 12 years and older with C3G and primary IC-MPGN ...

CONSHOHOCKEN, PA — Madrigal Pharmaceuticals (NASDAQ: MDGL) announced Monday it has secured exclusive global rights to develop ...